Nine-Month Results From Human

25 November 1996

Hungarian pharmaceuticals producer Human recorded gross profits of 553 million forint ($3.6 million) on consolidated net sales of 9.6 billion forint in the first nine months of the year, according to a report from MTI Econews. The firm's domestic turnover was 8.7 billion forint, while exports amounted to 901 million forint.

The firm's distribution subsidiary, Humantrade, recorded net sales of 6.7 billion forint, while Humanpharma, in which Human has a 30.4% stake, reported net sales of 709 million forint.

More Shares To Be Placed On Budapest Stock Exchange Human has announced that it will place another 90,000 of its shares on the Budapest Stock Exchange following the conversion of 90,000 employees' shares into ordinary shares, according to MTI Econews.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight